F. Trinker

Human albumin solutions: consensus statements for use in selected clinical situations. Subcommittee of the Victorian Drug Usage Advisory Committee.

M. Weyden, G. Whyte, M. Hemming, 1992, The Medical journal of Australia.

A STUDY OF PATIENTS WHO COME BY CHOICE TO THE CASUALTY DEPARTMENT OF THE ROYAL MELBOURNE HOSPITAL

J. Best, F. Trinker, M. Ewing, 1975, The Medical journal of Australia.

Pharmacological agents affecting the release and activity of catecholamines.

M. Rand, F. Trinker, 1966, British Journal of Anaesthesia.

Modification of synaptic transmission in the superior cervical ganglion by epinephrine, norepinephrine and nortriptyline.

D. F. Story, M. W. McCulloch, K. Cairncross, 1967, International journal of neuropharmacology.

The mechanism of the augmentation of responses to indirectly acting sympathomimetic amines by monoamine oxidase inhibitors.

M. Rand, F. Trinker, 1968, British journal of pharmacology and chemotherapy.

The effects of catecholamines on isolated perfused coronary arteries in the dog.

F. Trinker, 1973, Archives internationales de pharmacodynamie et de therapie.

The significance of the relative potencies of noradrenaline and α‐methylnoradrenaline for the mode of action of α‐methyldopa

F. Trinker, 1971 .

TRIAL OF A NEW HYPOTENSIVE DRUG — CLONIDINE (“CATAPRES”)

A. Barnett, F. Trinker, 1970, The Medical journal of Australia.